Managing the incidence of selective reporting bias: A survey of Cochrane review groups

Systematic Reviews

Volumn 4, Issue 1, 2015, Pages

  Reid, Emma K ^a   Tejani, Aaron M ^b   Huan, Lawrence N ^c   Egan, Gregory ^a   O'Sullivan, Cait ^d   Mayhew, Alain D ^e   Kabir, Monisha ^f  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Division of Infectious Diseases   (Canada)

^d Knowledge Synthesis Group Cochrane Methods Bias Ottawa Hospital Research Institute ^*  (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cochrane collaboration; Outcome reporting bias; Selective reporting bias; Systematic review

Indexed keywords

ARTICLE; AUTHOR; COCHRANE LIBRARY; CROSS-SECTIONAL STUDY; DATA PROCESSING; HUMAN; META ANALYSIS (TOPIC); METHODOLOGY; PEER REVIEW; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLISHING; SCIENTIFIC LITERATURE; SELECTIVE REPORTING BIAS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); INCIDENCE; LITERATURE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; SURVEYS AND QUESTIONNAIRES;

EID: 84939153304     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-015-0070-y     Document Type: Article

References (21)

1. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat. 2000;49(3):359-70.
2. Kirkham JJ, Dwan KM, Atlman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomized controlled trials on a cohort of systematic reviews. BMJ. 2010;340:c365. doi: 10.1136/bmj.c365 .
3. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3(8), e3081.
4. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org . Accessed 13 Dec 2014.
5. Norris SL, Holmer HK, Fu R, Ogden LA, Viswanathan MS, Abou-Setta AM. Clinical trial registries are of minimal use for identifying selective outcome and analysis reporting. Res Syn Meth. 2014;5:273-84.
6. Smyth RM, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ. 2010;341:c7153. doi: 10.1136/bmj.c7153 .
7. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385-96.
8. Dwan K, Kirkham JJ, Williamson PR, Gamble C. Selective reporting of outcomes in randomized controlled trials in systematic reviews of cystic fibrosis. BMJ Open. 2013;3(6), e002709.
9. The Cochrane Collaboration. Cochrane community: about us. 2014. http://www.cochrane.org/about-us . Accessed 19 May 2015.
10. Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D. Methodological standards for the conduct of new Cochrane Intervention Reviews. 2013: version 2.3. In: Methodological Expectations of Cochrane Intervention Reviews (MECIR). Cochrane Editorial Unit. 2013. http://editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013.pdf (2013). Accessed 19 Jan 2015.
11. Huan LN, Tejani AM, Egan G. Biomedical journals lack a consistent method to detect outcome reporting bias: a cross-sectional analysis. J Clin Pharm Ther. 2014;39(5):501-6. doi: 10.1111/jcpt.12172 .
12. Chan A, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200-7. doi: 10.7326/0003-4819-158-3-201302050-00583 .
13. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2004;141:477-8.
14. U.S. Food and Drug Administration: Food and Drug Administration Amendments Act (FDAAA) of 2007. http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/foodanddrugadministrationamendmentsactof2007/default.htm (2007) Accessed 17 Jan 2015.
15. Savovic J, Weeks L, Sterne JAC, Turner L, Altman DG, Moher D, et al. Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev. 2014;3:37. doi: 10.1186/2046-4053-3-37 .
16. Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson PR. Assessing the potential for outcome reporting bias in a review: a tutorial. Trials. 2010;11:52.
17. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbrouke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10), e296. doi: 10.1371/journal.pmed.0040296 .
18. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2. doi: 10.1186/2046-4053-1-2 .
19. Williamson PR, Clarke M. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative: its role in improving Cochrane Reviews [editorial]. Cochrane Database Syst Rev. 2012. doi: 10.1002/14651858.ED000041 .
20. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232 .
21. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535 .